nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—CYP2A6—lung cancer	0.418	1	CbGaD
Memantine—SLC22A2—Vinblastine—lung cancer	0.0458	0.214	CbGbCtD
Memantine—SLC22A2—Cisplatin—lung cancer	0.042	0.197	CbGbCtD
Memantine—CYP2C19—Gefitinib—lung cancer	0.0318	0.149	CbGbCtD
Memantine—CYP2C19—Teniposide—lung cancer	0.0309	0.144	CbGbCtD
Memantine—CYP2B6—Irinotecan—lung cancer	0.0267	0.125	CbGbCtD
Memantine—CYP2B6—Cisplatin—lung cancer	0.0218	0.102	CbGbCtD
Memantine—CYP2B6—Doxorubicin—lung cancer	0.0146	0.0684	CbGbCtD
Memantine—Confusional state—Docetaxel—lung cancer	5.18e-05	0.000206	CcSEcCtD
Memantine—Pharyngitis—Methotrexate—lung cancer	5.17e-05	0.000205	CcSEcCtD
Memantine—Urinary tract disorder—Methotrexate—lung cancer	5.14e-05	0.000204	CcSEcCtD
Memantine—Oedema—Docetaxel—lung cancer	5.13e-05	0.000204	CcSEcCtD
Memantine—Weight increased—Doxorubicin—lung cancer	5.13e-05	0.000204	CcSEcCtD
Memantine—Pruritus—Gemcitabine—lung cancer	5.12e-05	0.000203	CcSEcCtD
Memantine—Urethral disorder—Methotrexate—lung cancer	5.1e-05	0.000203	CcSEcCtD
Memantine—Infection—Docetaxel—lung cancer	5.1e-05	0.000203	CcSEcCtD
Memantine—Weight decreased—Doxorubicin—lung cancer	5.1e-05	0.000203	CcSEcCtD
Memantine—Feeling abnormal—Etoposide—lung cancer	5.09e-05	0.000202	CcSEcCtD
Memantine—Hyperglycaemia—Doxorubicin—lung cancer	5.08e-05	0.000202	CcSEcCtD
Memantine—Diarrhoea—Irinotecan—lung cancer	5.08e-05	0.000202	CcSEcCtD
Memantine—Pneumonia—Doxorubicin—lung cancer	5.05e-05	0.000201	CcSEcCtD
Memantine—Gastrointestinal pain—Etoposide—lung cancer	5.05e-05	0.000201	CcSEcCtD
Memantine—Shock—Docetaxel—lung cancer	5.05e-05	0.000201	CcSEcCtD
Memantine—Nervous system disorder—Docetaxel—lung cancer	5.03e-05	0.0002	CcSEcCtD
Memantine—Thrombocytopenia—Docetaxel—lung cancer	5.03e-05	0.0002	CcSEcCtD
Memantine—Infestation NOS—Doxorubicin—lung cancer	5.02e-05	0.0002	CcSEcCtD
Memantine—Infestation—Doxorubicin—lung cancer	5.02e-05	0.0002	CcSEcCtD
Memantine—Visual impairment—Methotrexate—lung cancer	5.02e-05	0.0002	CcSEcCtD
Memantine—Tachycardia—Docetaxel—lung cancer	5.01e-05	0.000199	CcSEcCtD
Memantine—Feeling abnormal—Paclitaxel—lung cancer	4.99e-05	0.000198	CcSEcCtD
Memantine—Skin disorder—Docetaxel—lung cancer	4.99e-05	0.000198	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	4.98e-05	0.000198	CcSEcCtD
Memantine—Hypersensitivity—Cisplatin—lung cancer	4.97e-05	0.000197	CcSEcCtD
Memantine—Gastrointestinal pain—Paclitaxel—lung cancer	4.95e-05	0.000197	CcSEcCtD
Memantine—Diarrhoea—Gemcitabine—lung cancer	4.95e-05	0.000197	CcSEcCtD
Memantine—Renal failure—Doxorubicin—lung cancer	4.94e-05	0.000196	CcSEcCtD
Memantine—Erythema multiforme—Methotrexate—lung cancer	4.92e-05	0.000196	CcSEcCtD
Memantine—Neuropathy peripheral—Doxorubicin—lung cancer	4.92e-05	0.000196	CcSEcCtD
Memantine—Dizziness—Irinotecan—lung cancer	4.91e-05	0.000195	CcSEcCtD
Memantine—Urticaria—Etoposide—lung cancer	4.91e-05	0.000195	CcSEcCtD
Memantine—Anorexia—Docetaxel—lung cancer	4.89e-05	0.000195	CcSEcCtD
Memantine—Abdominal pain—Etoposide—lung cancer	4.88e-05	0.000194	CcSEcCtD
Memantine—Body temperature increased—Etoposide—lung cancer	4.88e-05	0.000194	CcSEcCtD
Memantine—Conjunctivitis—Doxorubicin—lung cancer	4.88e-05	0.000194	CcSEcCtD
Memantine—Urinary tract infection—Doxorubicin—lung cancer	4.88e-05	0.000194	CcSEcCtD
Memantine—Eye disorder—Methotrexate—lung cancer	4.87e-05	0.000193	CcSEcCtD
Memantine—Tinnitus—Methotrexate—lung cancer	4.85e-05	0.000193	CcSEcCtD
Memantine—Asthenia—Cisplatin—lung cancer	4.84e-05	0.000192	CcSEcCtD
Memantine—Cardiac disorder—Methotrexate—lung cancer	4.83e-05	0.000192	CcSEcCtD
Memantine—Urticaria—Paclitaxel—lung cancer	4.81e-05	0.000191	CcSEcCtD
Memantine—Hypotension—Docetaxel—lung cancer	4.8e-05	0.000191	CcSEcCtD
Memantine—Haematuria—Doxorubicin—lung cancer	4.79e-05	0.00019	CcSEcCtD
Memantine—Body temperature increased—Paclitaxel—lung cancer	4.79e-05	0.00019	CcSEcCtD
Memantine—Abdominal pain—Paclitaxel—lung cancer	4.79e-05	0.00019	CcSEcCtD
Memantine—Hepatobiliary disease—Doxorubicin—lung cancer	4.75e-05	0.000189	CcSEcCtD
Memantine—Epistaxis—Doxorubicin—lung cancer	4.74e-05	0.000188	CcSEcCtD
Memantine—Angiopathy—Methotrexate—lung cancer	4.72e-05	0.000188	CcSEcCtD
Memantine—Vomiting—Irinotecan—lung cancer	4.72e-05	0.000188	CcSEcCtD
Memantine—Sinusitis—Doxorubicin—lung cancer	4.71e-05	0.000187	CcSEcCtD
Memantine—Immune system disorder—Methotrexate—lung cancer	4.7e-05	0.000187	CcSEcCtD
Memantine—Mediastinal disorder—Methotrexate—lung cancer	4.69e-05	0.000187	CcSEcCtD
Memantine—Agranulocytosis—Doxorubicin—lung cancer	4.69e-05	0.000186	CcSEcCtD
Memantine—Rash—Irinotecan—lung cancer	4.68e-05	0.000186	CcSEcCtD
Memantine—Dermatitis—Irinotecan—lung cancer	4.68e-05	0.000186	CcSEcCtD
Memantine—Musculoskeletal discomfort—Docetaxel—lung cancer	4.68e-05	0.000186	CcSEcCtD
Memantine—Chills—Methotrexate—lung cancer	4.67e-05	0.000186	CcSEcCtD
Memantine—Headache—Irinotecan—lung cancer	4.65e-05	0.000185	CcSEcCtD
Memantine—Insomnia—Docetaxel—lung cancer	4.64e-05	0.000185	CcSEcCtD
Memantine—Diarrhoea—Cisplatin—lung cancer	4.61e-05	0.000183	CcSEcCtD
Memantine—Paraesthesia—Docetaxel—lung cancer	4.61e-05	0.000183	CcSEcCtD
Memantine—Alopecia—Methotrexate—lung cancer	4.6e-05	0.000183	CcSEcCtD
Memantine—Vomiting—Gemcitabine—lung cancer	4.6e-05	0.000183	CcSEcCtD
Memantine—Bradycardia—Doxorubicin—lung cancer	4.59e-05	0.000182	CcSEcCtD
Memantine—Dyspnoea—Docetaxel—lung cancer	4.58e-05	0.000182	CcSEcCtD
Memantine—Somnolence—Docetaxel—lung cancer	4.56e-05	0.000181	CcSEcCtD
Memantine—Mental disorder—Methotrexate—lung cancer	4.56e-05	0.000181	CcSEcCtD
Memantine—Rash—Gemcitabine—lung cancer	4.56e-05	0.000181	CcSEcCtD
Memantine—Dermatitis—Gemcitabine—lung cancer	4.56e-05	0.000181	CcSEcCtD
Memantine—Hypersensitivity—Etoposide—lung cancer	4.55e-05	0.000181	CcSEcCtD
Memantine—Malnutrition—Methotrexate—lung cancer	4.53e-05	0.00018	CcSEcCtD
Memantine—Haemoglobin—Doxorubicin—lung cancer	4.53e-05	0.00018	CcSEcCtD
Memantine—Headache—Gemcitabine—lung cancer	4.53e-05	0.00018	CcSEcCtD
Memantine—Rhinitis—Doxorubicin—lung cancer	4.52e-05	0.00018	CcSEcCtD
Memantine—Dyspepsia—Docetaxel—lung cancer	4.52e-05	0.00018	CcSEcCtD
Memantine—Haemorrhage—Doxorubicin—lung cancer	4.51e-05	0.000179	CcSEcCtD
Memantine—Hepatitis—Doxorubicin—lung cancer	4.51e-05	0.000179	CcSEcCtD
Memantine—Hypoaesthesia—Doxorubicin—lung cancer	4.49e-05	0.000178	CcSEcCtD
Memantine—Pharyngitis—Doxorubicin—lung cancer	4.47e-05	0.000178	CcSEcCtD
Memantine—Decreased appetite—Docetaxel—lung cancer	4.46e-05	0.000177	CcSEcCtD
Memantine—Hypersensitivity—Paclitaxel—lung cancer	4.46e-05	0.000177	CcSEcCtD
Memantine—Urinary tract disorder—Doxorubicin—lung cancer	4.45e-05	0.000177	CcSEcCtD
Memantine—Oedema peripheral—Doxorubicin—lung cancer	4.44e-05	0.000177	CcSEcCtD
Memantine—Dysgeusia—Methotrexate—lung cancer	4.44e-05	0.000176	CcSEcCtD
Memantine—Gastrointestinal disorder—Docetaxel—lung cancer	4.43e-05	0.000176	CcSEcCtD
Memantine—Asthenia—Etoposide—lung cancer	4.43e-05	0.000176	CcSEcCtD
Memantine—Connective tissue disorder—Doxorubicin—lung cancer	4.43e-05	0.000176	CcSEcCtD
Memantine—Fatigue—Docetaxel—lung cancer	4.43e-05	0.000176	CcSEcCtD
Memantine—Urethral disorder—Doxorubicin—lung cancer	4.42e-05	0.000176	CcSEcCtD
Memantine—Nausea—Irinotecan—lung cancer	4.41e-05	0.000175	CcSEcCtD
Memantine—Pain—Docetaxel—lung cancer	4.39e-05	0.000175	CcSEcCtD
Memantine—Constipation—Docetaxel—lung cancer	4.39e-05	0.000175	CcSEcCtD
Memantine—Back pain—Methotrexate—lung cancer	4.38e-05	0.000174	CcSEcCtD
Memantine—Pruritus—Etoposide—lung cancer	4.37e-05	0.000174	CcSEcCtD
Memantine—Visual impairment—Doxorubicin—lung cancer	4.34e-05	0.000173	CcSEcCtD
Memantine—Asthenia—Paclitaxel—lung cancer	4.34e-05	0.000173	CcSEcCtD
Memantine—Nausea—Gemcitabine—lung cancer	4.3e-05	0.000171	CcSEcCtD
Memantine—Vomiting—Cisplatin—lung cancer	4.29e-05	0.00017	CcSEcCtD
Memantine—Pruritus—Paclitaxel—lung cancer	4.28e-05	0.00017	CcSEcCtD
Memantine—Vision blurred—Methotrexate—lung cancer	4.27e-05	0.00017	CcSEcCtD
Memantine—Erythema multiforme—Doxorubicin—lung cancer	4.26e-05	0.000169	CcSEcCtD
Memantine—Rash—Cisplatin—lung cancer	4.25e-05	0.000169	CcSEcCtD
Memantine—Dermatitis—Cisplatin—lung cancer	4.25e-05	0.000169	CcSEcCtD
Memantine—Feeling abnormal—Docetaxel—lung cancer	4.23e-05	0.000168	CcSEcCtD
Memantine—Diarrhoea—Etoposide—lung cancer	4.23e-05	0.000168	CcSEcCtD
Memantine—Eye disorder—Doxorubicin—lung cancer	4.21e-05	0.000168	CcSEcCtD
Memantine—Ill-defined disorder—Methotrexate—lung cancer	4.21e-05	0.000167	CcSEcCtD
Memantine—Tinnitus—Doxorubicin—lung cancer	4.2e-05	0.000167	CcSEcCtD
Memantine—Gastrointestinal pain—Docetaxel—lung cancer	4.2e-05	0.000167	CcSEcCtD
Memantine—Anaemia—Methotrexate—lung cancer	4.19e-05	0.000167	CcSEcCtD
Memantine—Cardiac disorder—Doxorubicin—lung cancer	4.18e-05	0.000166	CcSEcCtD
Memantine—Flushing—Doxorubicin—lung cancer	4.18e-05	0.000166	CcSEcCtD
Memantine—Diarrhoea—Paclitaxel—lung cancer	4.14e-05	0.000165	CcSEcCtD
Memantine—Angiopathy—Doxorubicin—lung cancer	4.09e-05	0.000163	CcSEcCtD
Memantine—Malaise—Methotrexate—lung cancer	4.09e-05	0.000163	CcSEcCtD
Memantine—Dizziness—Etoposide—lung cancer	4.08e-05	0.000162	CcSEcCtD
Memantine—Immune system disorder—Doxorubicin—lung cancer	4.07e-05	0.000162	CcSEcCtD
Memantine—Vertigo—Methotrexate—lung cancer	4.07e-05	0.000162	CcSEcCtD
Memantine—Mediastinal disorder—Doxorubicin—lung cancer	4.06e-05	0.000162	CcSEcCtD
Memantine—Body temperature increased—Docetaxel—lung cancer	4.06e-05	0.000161	CcSEcCtD
Memantine—Abdominal pain—Docetaxel—lung cancer	4.06e-05	0.000161	CcSEcCtD
Memantine—Leukopenia—Methotrexate—lung cancer	4.06e-05	0.000161	CcSEcCtD
Memantine—Chills—Doxorubicin—lung cancer	4.05e-05	0.000161	CcSEcCtD
Memantine—Arrhythmia—Doxorubicin—lung cancer	4.03e-05	0.00016	CcSEcCtD
Memantine—Dizziness—Paclitaxel—lung cancer	4e-05	0.000159	CcSEcCtD
Memantine—Nausea—Cisplatin—lung cancer	4e-05	0.000159	CcSEcCtD
Memantine—Alopecia—Doxorubicin—lung cancer	3.98e-05	0.000158	CcSEcCtD
Memantine—Cough—Methotrexate—lung cancer	3.96e-05	0.000157	CcSEcCtD
Memantine—Mental disorder—Doxorubicin—lung cancer	3.95e-05	0.000157	CcSEcCtD
Memantine—Convulsion—Methotrexate—lung cancer	3.93e-05	0.000156	CcSEcCtD
Memantine—Vomiting—Etoposide—lung cancer	3.93e-05	0.000156	CcSEcCtD
Memantine—Malnutrition—Doxorubicin—lung cancer	3.92e-05	0.000156	CcSEcCtD
Memantine—Rash—Etoposide—lung cancer	3.89e-05	0.000155	CcSEcCtD
Memantine—Dermatitis—Etoposide—lung cancer	3.89e-05	0.000155	CcSEcCtD
Memantine—Headache—Etoposide—lung cancer	3.87e-05	0.000154	CcSEcCtD
Memantine—Flatulence—Doxorubicin—lung cancer	3.87e-05	0.000154	CcSEcCtD
Memantine—Chest pain—Methotrexate—lung cancer	3.86e-05	0.000153	CcSEcCtD
Memantine—Arthralgia—Methotrexate—lung cancer	3.86e-05	0.000153	CcSEcCtD
Memantine—Myalgia—Methotrexate—lung cancer	3.86e-05	0.000153	CcSEcCtD
Memantine—Tension—Doxorubicin—lung cancer	3.85e-05	0.000153	CcSEcCtD
Memantine—Vomiting—Paclitaxel—lung cancer	3.85e-05	0.000153	CcSEcCtD
Memantine—Dysgeusia—Doxorubicin—lung cancer	3.84e-05	0.000153	CcSEcCtD
Memantine—Rash—Paclitaxel—lung cancer	3.82e-05	0.000152	CcSEcCtD
Memantine—Dermatitis—Paclitaxel—lung cancer	3.81e-05	0.000152	CcSEcCtD
Memantine—Discomfort—Methotrexate—lung cancer	3.81e-05	0.000152	CcSEcCtD
Memantine—Nervousness—Doxorubicin—lung cancer	3.81e-05	0.000152	CcSEcCtD
Memantine—Back pain—Doxorubicin—lung cancer	3.8e-05	0.000151	CcSEcCtD
Memantine—Headache—Paclitaxel—lung cancer	3.79e-05	0.000151	CcSEcCtD
Memantine—Hypersensitivity—Docetaxel—lung cancer	3.78e-05	0.00015	CcSEcCtD
Memantine—Confusional state—Methotrexate—lung cancer	3.73e-05	0.000148	CcSEcCtD
Memantine—Vision blurred—Doxorubicin—lung cancer	3.7e-05	0.000147	CcSEcCtD
Memantine—Asthenia—Docetaxel—lung cancer	3.68e-05	0.000146	CcSEcCtD
Memantine—Infection—Methotrexate—lung cancer	3.68e-05	0.000146	CcSEcCtD
Memantine—Nausea—Etoposide—lung cancer	3.67e-05	0.000146	CcSEcCtD
Memantine—Ill-defined disorder—Doxorubicin—lung cancer	3.64e-05	0.000145	CcSEcCtD
Memantine—Pruritus—Docetaxel—lung cancer	3.63e-05	0.000144	CcSEcCtD
Memantine—Nervous system disorder—Methotrexate—lung cancer	3.63e-05	0.000144	CcSEcCtD
Memantine—Anaemia—Doxorubicin—lung cancer	3.63e-05	0.000144	CcSEcCtD
Memantine—Thrombocytopenia—Methotrexate—lung cancer	3.62e-05	0.000144	CcSEcCtD
Memantine—Agitation—Doxorubicin—lung cancer	3.61e-05	0.000143	CcSEcCtD
Memantine—Nausea—Paclitaxel—lung cancer	3.6e-05	0.000143	CcSEcCtD
Memantine—Skin disorder—Methotrexate—lung cancer	3.59e-05	0.000143	CcSEcCtD
Memantine—Hyperhidrosis—Methotrexate—lung cancer	3.58e-05	0.000142	CcSEcCtD
Memantine—Malaise—Doxorubicin—lung cancer	3.54e-05	0.000141	CcSEcCtD
Memantine—Vertigo—Doxorubicin—lung cancer	3.53e-05	0.00014	CcSEcCtD
Memantine—Anorexia—Methotrexate—lung cancer	3.53e-05	0.00014	CcSEcCtD
Memantine—Syncope—Doxorubicin—lung cancer	3.52e-05	0.00014	CcSEcCtD
Memantine—Leukopenia—Doxorubicin—lung cancer	3.51e-05	0.00014	CcSEcCtD
Memantine—Diarrhoea—Docetaxel—lung cancer	3.51e-05	0.00014	CcSEcCtD
Memantine—Palpitations—Doxorubicin—lung cancer	3.47e-05	0.000138	CcSEcCtD
Memantine—Hypotension—Methotrexate—lung cancer	3.46e-05	0.000137	CcSEcCtD
Memantine—Loss of consciousness—Doxorubicin—lung cancer	3.45e-05	0.000137	CcSEcCtD
Memantine—Cough—Doxorubicin—lung cancer	3.42e-05	0.000136	CcSEcCtD
Memantine—Convulsion—Doxorubicin—lung cancer	3.4e-05	0.000135	CcSEcCtD
Memantine—Dizziness—Docetaxel—lung cancer	3.39e-05	0.000135	CcSEcCtD
Memantine—Hypertension—Doxorubicin—lung cancer	3.39e-05	0.000135	CcSEcCtD
Memantine—Musculoskeletal discomfort—Methotrexate—lung cancer	3.37e-05	0.000134	CcSEcCtD
Memantine—Insomnia—Methotrexate—lung cancer	3.35e-05	0.000133	CcSEcCtD
Memantine—Arthralgia—Doxorubicin—lung cancer	3.34e-05	0.000133	CcSEcCtD
Memantine—Myalgia—Doxorubicin—lung cancer	3.34e-05	0.000133	CcSEcCtD
Memantine—Chest pain—Doxorubicin—lung cancer	3.34e-05	0.000133	CcSEcCtD
Memantine—Anxiety—Doxorubicin—lung cancer	3.33e-05	0.000132	CcSEcCtD
Memantine—Paraesthesia—Methotrexate—lung cancer	3.32e-05	0.000132	CcSEcCtD
Memantine—Discomfort—Doxorubicin—lung cancer	3.3e-05	0.000131	CcSEcCtD
Memantine—Dyspnoea—Methotrexate—lung cancer	3.3e-05	0.000131	CcSEcCtD
Memantine—Somnolence—Methotrexate—lung cancer	3.29e-05	0.000131	CcSEcCtD
Memantine—Dry mouth—Doxorubicin—lung cancer	3.27e-05	0.00013	CcSEcCtD
Memantine—Vomiting—Docetaxel—lung cancer	3.26e-05	0.00013	CcSEcCtD
Memantine—Dyspepsia—Methotrexate—lung cancer	3.26e-05	0.000129	CcSEcCtD
Memantine—Rash—Docetaxel—lung cancer	3.24e-05	0.000129	CcSEcCtD
Memantine—Dermatitis—Docetaxel—lung cancer	3.23e-05	0.000129	CcSEcCtD
Memantine—Confusional state—Doxorubicin—lung cancer	3.23e-05	0.000128	CcSEcCtD
Memantine—Decreased appetite—Methotrexate—lung cancer	3.22e-05	0.000128	CcSEcCtD
Memantine—Headache—Docetaxel—lung cancer	3.22e-05	0.000128	CcSEcCtD
Memantine—Oedema—Doxorubicin—lung cancer	3.2e-05	0.000127	CcSEcCtD
Memantine—Gastrointestinal disorder—Methotrexate—lung cancer	3.19e-05	0.000127	CcSEcCtD
Memantine—Fatigue—Methotrexate—lung cancer	3.19e-05	0.000127	CcSEcCtD
Memantine—Infection—Doxorubicin—lung cancer	3.18e-05	0.000127	CcSEcCtD
Memantine—Pain—Methotrexate—lung cancer	3.16e-05	0.000126	CcSEcCtD
Memantine—Shock—Doxorubicin—lung cancer	3.15e-05	0.000125	CcSEcCtD
Memantine—Nervous system disorder—Doxorubicin—lung cancer	3.14e-05	0.000125	CcSEcCtD
Memantine—Thrombocytopenia—Doxorubicin—lung cancer	3.14e-05	0.000125	CcSEcCtD
Memantine—Tachycardia—Doxorubicin—lung cancer	3.13e-05	0.000124	CcSEcCtD
Memantine—Skin disorder—Doxorubicin—lung cancer	3.11e-05	0.000124	CcSEcCtD
Memantine—Hyperhidrosis—Doxorubicin—lung cancer	3.1e-05	0.000123	CcSEcCtD
Memantine—Anorexia—Doxorubicin—lung cancer	3.05e-05	0.000121	CcSEcCtD
Memantine—Nausea—Docetaxel—lung cancer	3.05e-05	0.000121	CcSEcCtD
Memantine—Feeling abnormal—Methotrexate—lung cancer	3.05e-05	0.000121	CcSEcCtD
Memantine—Gastrointestinal pain—Methotrexate—lung cancer	3.02e-05	0.00012	CcSEcCtD
Memantine—Hypotension—Doxorubicin—lung cancer	2.99e-05	0.000119	CcSEcCtD
Memantine—Urticaria—Methotrexate—lung cancer	2.94e-05	0.000117	CcSEcCtD
Memantine—Abdominal pain—Methotrexate—lung cancer	2.92e-05	0.000116	CcSEcCtD
Memantine—Body temperature increased—Methotrexate—lung cancer	2.92e-05	0.000116	CcSEcCtD
Memantine—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.92e-05	0.000116	CcSEcCtD
Memantine—Insomnia—Doxorubicin—lung cancer	2.9e-05	0.000115	CcSEcCtD
Memantine—Paraesthesia—Doxorubicin—lung cancer	2.88e-05	0.000114	CcSEcCtD
Memantine—Dyspnoea—Doxorubicin—lung cancer	2.86e-05	0.000114	CcSEcCtD
Memantine—Somnolence—Doxorubicin—lung cancer	2.85e-05	0.000113	CcSEcCtD
Memantine—Dyspepsia—Doxorubicin—lung cancer	2.82e-05	0.000112	CcSEcCtD
Memantine—Decreased appetite—Doxorubicin—lung cancer	2.78e-05	0.000111	CcSEcCtD
Memantine—Gastrointestinal disorder—Doxorubicin—lung cancer	2.77e-05	0.00011	CcSEcCtD
Memantine—Fatigue—Doxorubicin—lung cancer	2.76e-05	0.00011	CcSEcCtD
Memantine—Constipation—Doxorubicin—lung cancer	2.74e-05	0.000109	CcSEcCtD
Memantine—Pain—Doxorubicin—lung cancer	2.74e-05	0.000109	CcSEcCtD
Memantine—Hypersensitivity—Methotrexate—lung cancer	2.73e-05	0.000108	CcSEcCtD
Memantine—Asthenia—Methotrexate—lung cancer	2.65e-05	0.000106	CcSEcCtD
Memantine—Feeling abnormal—Doxorubicin—lung cancer	2.64e-05	0.000105	CcSEcCtD
Memantine—Gastrointestinal pain—Doxorubicin—lung cancer	2.62e-05	0.000104	CcSEcCtD
Memantine—Pruritus—Methotrexate—lung cancer	2.62e-05	0.000104	CcSEcCtD
Memantine—Urticaria—Doxorubicin—lung cancer	2.54e-05	0.000101	CcSEcCtD
Memantine—Body temperature increased—Doxorubicin—lung cancer	2.53e-05	0.000101	CcSEcCtD
Memantine—Abdominal pain—Doxorubicin—lung cancer	2.53e-05	0.000101	CcSEcCtD
Memantine—Diarrhoea—Methotrexate—lung cancer	2.53e-05	0.000101	CcSEcCtD
Memantine—Dizziness—Methotrexate—lung cancer	2.45e-05	9.73e-05	CcSEcCtD
Memantine—Hypersensitivity—Doxorubicin—lung cancer	2.36e-05	9.38e-05	CcSEcCtD
Memantine—Vomiting—Methotrexate—lung cancer	2.35e-05	9.35e-05	CcSEcCtD
Memantine—Rash—Methotrexate—lung cancer	2.33e-05	9.27e-05	CcSEcCtD
Memantine—Dermatitis—Methotrexate—lung cancer	2.33e-05	9.26e-05	CcSEcCtD
Memantine—Headache—Methotrexate—lung cancer	2.32e-05	9.21e-05	CcSEcCtD
Memantine—Asthenia—Doxorubicin—lung cancer	2.3e-05	9.14e-05	CcSEcCtD
Memantine—Pruritus—Doxorubicin—lung cancer	2.27e-05	9.01e-05	CcSEcCtD
Memantine—Nausea—Methotrexate—lung cancer	2.2e-05	8.74e-05	CcSEcCtD
Memantine—Diarrhoea—Doxorubicin—lung cancer	2.19e-05	8.71e-05	CcSEcCtD
Memantine—Dizziness—Doxorubicin—lung cancer	2.12e-05	8.42e-05	CcSEcCtD
Memantine—Vomiting—Doxorubicin—lung cancer	2.04e-05	8.1e-05	CcSEcCtD
Memantine—Rash—Doxorubicin—lung cancer	2.02e-05	8.03e-05	CcSEcCtD
Memantine—Dermatitis—Doxorubicin—lung cancer	2.02e-05	8.02e-05	CcSEcCtD
Memantine—Headache—Doxorubicin—lung cancer	2.01e-05	7.98e-05	CcSEcCtD
Memantine—Nausea—Doxorubicin—lung cancer	1.9e-05	7.56e-05	CcSEcCtD
Memantine—CYP2A6—Metabolism—ADCY1—lung cancer	1.57e-05	0.000134	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ABCG2—lung cancer	1.57e-05	0.000134	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—HRAS—lung cancer	1.57e-05	0.000134	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ABCC3—lung cancer	1.55e-05	0.000133	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP2A7—lung cancer	1.55e-05	0.000133	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—HPGDS—lung cancer	1.54e-05	0.000132	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ENO2—lung cancer	1.54e-05	0.000132	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—IL6—lung cancer	1.54e-05	0.000132	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PXN—lung cancer	1.53e-05	0.000131	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PPP2R1B—lung cancer	1.53e-05	0.000131	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ENO1—lung cancer	1.52e-05	0.00013	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—CREBBP—lung cancer	1.52e-05	0.00013	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SDC4—lung cancer	1.52e-05	0.00013	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AVP—lung cancer	1.52e-05	0.00013	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AKR1C1—lung cancer	1.5e-05	0.000129	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—IL6—lung cancer	1.5e-05	0.000128	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—OXTR—lung cancer	1.5e-05	0.000128	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKR1C1—lung cancer	1.5e-05	0.000128	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GRP—lung cancer	1.5e-05	0.000128	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTT1—lung cancer	1.49e-05	0.000128	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GCLC—lung cancer	1.48e-05	0.000126	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—UGT1A1—lung cancer	1.46e-05	0.000125	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—IL6—lung cancer	1.45e-05	0.000124	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—ALB—lung cancer	1.43e-05	0.000122	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—AKT1—lung cancer	1.42e-05	0.000121	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GNG11—lung cancer	1.41e-05	0.00012	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GNG11—lung cancer	1.4e-05	0.00012	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ENO1—lung cancer	1.4e-05	0.00012	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—AKT1—lung cancer	1.38e-05	0.000118	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTA3—lung cancer	1.38e-05	0.000118	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—RRM1—lung cancer	1.38e-05	0.000118	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CXCL8—lung cancer	1.38e-05	0.000118	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AVP—lung cancer	1.38e-05	0.000118	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP2E1—lung cancer	1.37e-05	0.000117	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—NQO1—lung cancer	1.35e-05	0.000116	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ALDOA—lung cancer	1.34e-05	0.000115	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFC—lung cancer	1.34e-05	0.000114	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—HRAS—lung cancer	1.32e-05	0.000113	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—NCOA3—lung cancer	1.3e-05	0.000111	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—B4GALT5—lung cancer	1.3e-05	0.000111	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—RAF1—lung cancer	1.29e-05	0.00011	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ADCY1—lung cancer	1.27e-05	0.000108	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ABCG2—lung cancer	1.27e-05	0.000108	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTA4—lung cancer	1.26e-05	0.000108	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ADCY1—lung cancer	1.26e-05	0.000108	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP2E1—lung cancer	1.26e-05	0.000107	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ENO2—lung cancer	1.24e-05	0.000106	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—HPGDS—lung cancer	1.24e-05	0.000106	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—NQO1—lung cancer	1.24e-05	0.000106	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.23e-05	0.000106	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PPP2R1B—lung cancer	1.23e-05	0.000106	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTA2—lung cancer	1.23e-05	0.000105	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PPP2R1B—lung cancer	1.23e-05	0.000105	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SMARCA4—lung cancer	1.23e-05	0.000105	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—STK11—lung cancer	1.22e-05	0.000104	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTT1—lung cancer	1.2e-05	0.000103	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP2A6—lung cancer	1.19e-05	0.000102	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GCLC—lung cancer	1.19e-05	0.000102	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTA1—lung cancer	1.19e-05	0.000102	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HSPB1—lung cancer	1.19e-05	0.000101	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ABCC3—lung cancer	1.17e-05	0.0001	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTHLH—lung cancer	1.17e-05	0.0001	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AKR1C1—lung cancer	1.14e-05	9.73e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ENO1—lung cancer	1.13e-05	9.66e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTP1—lung cancer	1.13e-05	9.64e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—STK11—lung cancer	1.12e-05	9.57e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—UGT1A1—lung cancer	1.1e-05	9.44e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ANXA1—lung cancer	1.1e-05	9.44e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CAT—lung cancer	1.1e-05	9.38e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FLT1—lung cancer	1.07e-05	9.14e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ABCB1—lung cancer	1.07e-05	9.13e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GNG11—lung cancer	1.06e-05	9.11e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.06e-05	9.06e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CG—lung cancer	1.06e-05	9.05e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—TYMS—lung cancer	1.05e-05	8.97e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APP—lung cancer	1.05e-05	8.94e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NOTCH3—lung cancer	1.05e-05	8.94e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FGF9—lung cancer	1.04e-05	8.87e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GSTM1—lung cancer	1.04e-05	8.86e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTP1—lung cancer	1.04e-05	8.85e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALDOA—lung cancer	1.01e-05	8.67e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP2E1—lung cancer	1.01e-05	8.66e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—POMC—lung cancer	1.01e-05	8.62e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CAT—lung cancer	1.01e-05	8.62e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—NQO1—lung cancer	1e-05	8.56e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—JUNB—lung cancer	9.9e-06	8.47e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NCOA3—lung cancer	9.84e-06	8.42e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP1A1—lung cancer	9.82e-06	8.4e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ABCB1—lung cancer	9.8e-06	8.38e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ERCC2—lung cancer	9.74e-06	8.33e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	9.67e-06	8.27e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—TYMS—lung cancer	9.62e-06	8.23e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CG—lung cancer	9.61e-06	8.22e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ADCY1—lung cancer	9.57e-06	8.19e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ABCG2—lung cancer	9.57e-06	8.19e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GSTM1—lung cancer	9.51e-06	8.14e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—HPGDS—lung cancer	9.39e-06	8.03e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ENO2—lung cancer	9.39e-06	8.03e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PPP2R1B—lung cancer	9.33e-06	7.98e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CD—lung cancer	9.3e-06	7.96e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	9.2e-06	7.87e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—POMC—lung cancer	9.15e-06	7.83e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTT1—lung cancer	9.1e-06	7.79e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—STK11—lung cancer	9.03e-06	7.72e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP1A1—lung cancer	9.02e-06	7.71e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GCLC—lung cancer	9e-06	7.7e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP2A6—lung cancer	9e-06	7.7e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—STK11—lung cancer	8.99e-06	7.69e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	8.96e-06	7.67e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ERCC2—lung cancer	8.94e-06	7.65e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL6R—lung cancer	8.92e-06	7.63e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FOXO3—lung cancer	8.68e-06	7.42e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ENO1—lung cancer	8.53e-06	7.3e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—MAP2K1—lung cancer	8.5e-06	7.27e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	8.5e-06	7.27e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CD—lung cancer	8.45e-06	7.23e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—APOA1—lung cancer	8.43e-06	7.21e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	8.39e-06	7.18e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTP1—lung cancer	8.35e-06	7.14e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AVP—lung cancer	8.13e-06	6.96e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CAT—lung cancer	8.13e-06	6.95e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CB—lung cancer	8.11e-06	6.94e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ABCB1—lung cancer	7.9e-06	6.76e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IGF1R—lung cancer	7.83e-06	6.7e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CXCL8—lung cancer	7.79e-06	6.67e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—TYMS—lung cancer	7.76e-06	6.64e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—APOA1—lung cancer	7.74e-06	6.62e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CG—lung cancer	7.69e-06	6.58e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HES1—lung cancer	7.69e-06	6.58e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GSTM1—lung cancer	7.67e-06	6.56e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP2E1—lung cancer	7.65e-06	6.55e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NQO1—lung cancer	7.57e-06	6.47e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—RAF1—lung cancer	7.54e-06	6.45e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—IL2—lung cancer	7.45e-06	6.37e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.41e-06	6.34e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CB—lung cancer	7.36e-06	6.3e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.34e-06	6.28e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—POMC—lung cancer	7.32e-06	6.26e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP1A1—lung cancer	7.27e-06	6.22e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ERCC2—lung cancer	7.22e-06	6.17e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CREBBP—lung cancer	7.13e-06	6.1e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CXCL8—lung cancer	7.08e-06	6.05e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CG—lung cancer	7.06e-06	6.04e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ERBB3—lung cancer	7.03e-06	6.01e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—STK11—lung cancer	6.82e-06	5.83e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CD—lung cancer	6.76e-06	5.79e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL2—lung cancer	6.76e-06	5.79e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TERT—lung cancer	6.74e-06	5.76e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—POMC—lung cancer	6.72e-06	5.75e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ALB—lung cancer	6.68e-06	5.71e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CREBBP—lung cancer	6.55e-06	5.6e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—FGFR1—lung cancer	6.54e-06	5.6e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HIF1A—lung cancer	6.44e-06	5.51e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.4e-06	5.48e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTP1—lung cancer	6.31e-06	5.4e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—APOA1—lung cancer	6.24e-06	5.34e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APOA1—lung cancer	6.22e-06	5.32e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CD—lung cancer	6.21e-06	5.31e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KDR—lung cancer	6.16e-06	5.27e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CAT—lung cancer	6.14e-06	5.25e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ALB—lung cancer	6.13e-06	5.24e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.11e-06	5.22e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ABCB1—lung cancer	5.97e-06	5.11e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CB—lung cancer	5.89e-06	5.04e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TYMS—lung cancer	5.87e-06	5.02e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTGS2—lung cancer	5.84e-06	5e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GSTM1—lung cancer	5.8e-06	4.96e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CG—lung cancer	5.7e-06	4.87e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CG—lung cancer	5.68e-06	4.86e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KIT—lung cancer	5.68e-06	4.86e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APC—lung cancer	5.68e-06	4.86e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—NRAS—lung cancer	5.68e-06	4.86e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EGF—lung cancer	5.61e-06	4.8e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP1A1—lung cancer	5.5e-06	4.7e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ERCC2—lung cancer	5.45e-06	4.66e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—MAPK3—lung cancer	5.44e-06	4.65e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—POMC—lung cancer	5.42e-06	4.64e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CB—lung cancer	5.41e-06	4.63e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—POMC—lung cancer	5.4e-06	4.62e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTGS2—lung cancer	5.36e-06	4.59e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—BRAF—lung cancer	5.34e-06	4.56e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CREBBP—lung cancer	5.28e-06	4.52e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL6R—lung cancer	5.27e-06	4.51e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CREBBP—lung cancer	5.26e-06	4.5e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—EGFR—lung cancer	5.17e-06	4.42e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PTEN—lung cancer	5.09e-06	4.36e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MAP2K1—lung cancer	5.02e-06	4.3e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CD—lung cancer	5.01e-06	4.28e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CD—lung cancer	4.99e-06	4.27e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ALB—lung cancer	4.95e-06	4.23e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PIK3CA—lung cancer	4.94e-06	4.23e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—KRAS—lung cancer	4.89e-06	4.18e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—EP300—lung cancer	4.86e-06	4.16e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—APOA1—lung cancer	4.72e-06	4.03e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PTEN—lung cancer	4.68e-06	4e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.52e-06	3.86e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PIK3CA—lung cancer	4.49e-06	3.84e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MDM2—lung cancer	4.47e-06	3.82e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—EP300—lung cancer	4.46e-06	3.81e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RAF1—lung cancer	4.46e-06	3.81e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ERBB2—lung cancer	4.41e-06	3.77e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CB—lung cancer	4.37e-06	3.73e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MTOR—lung cancer	4.35e-06	3.72e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CB—lung cancer	4.35e-06	3.72e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTGS2—lung cancer	4.33e-06	3.7e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CG—lung cancer	4.31e-06	3.68e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCL8—lung cancer	4.18e-06	3.58e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—HRAS—lung cancer	4.15e-06	3.55e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—POMC—lung cancer	4.1e-06	3.51e-05	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AKT1—lung cancer	4.04e-06	3.45e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CASP3—lung cancer	4e-06	3.42e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL2—lung cancer	4e-06	3.42e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CREBBP—lung cancer	3.99e-06	3.42e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL6—lung cancer	3.98e-06	3.4e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCND1—lung cancer	3.89e-06	3.33e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—JUN—lung cancer	3.89e-06	3.32e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CD—lung cancer	3.79e-06	3.24e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MMP9—lung cancer	3.78e-06	3.23e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PTEN—lung cancer	3.77e-06	3.23e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CDKN1A—lung cancer	3.77e-06	3.22e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTEN—lung cancer	3.76e-06	3.22e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALB—lung cancer	3.74e-06	3.2e-05	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AKT1—lung cancer	3.67e-06	3.14e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—EP300—lung cancer	3.6e-06	3.08e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3CA—lung cancer	3.59e-06	3.07e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EP300—lung cancer	3.58e-06	3.07e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SRC—lung cancer	3.49e-06	2.98e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VEGFA—lung cancer	3.4e-06	2.9e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—STAT3—lung cancer	3.36e-06	2.88e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NRAS—lung cancer	3.35e-06	2.87e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CB—lung cancer	3.3e-06	2.82e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3CA—lung cancer	3.3e-06	2.82e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTGS2—lung cancer	3.27e-06	2.8e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MAPK3—lung cancer	3.21e-06	2.75e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MYC—lung cancer	3.12e-06	2.67e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—EGFR—lung cancer	3.06e-06	2.61e-05	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AKT1—lung cancer	2.94e-06	2.51e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KRAS—lung cancer	2.89e-06	2.47e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PTEN—lung cancer	2.85e-06	2.44e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—EP300—lung cancer	2.72e-06	2.33e-05	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AKT1—lung cancer	2.69e-06	2.31e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3CA—lung cancer	2.66e-06	2.28e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PIK3CA—lung cancer	2.65e-06	2.27e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TP53—lung cancer	2.57e-06	2.19e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HRAS—lung cancer	2.45e-06	2.1e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL6—lung cancer	2.35e-06	2.01e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AKT1—lung cancer	2.17e-06	1.86e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKT1—lung cancer	2.17e-06	1.85e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3CA—lung cancer	2.01e-06	1.72e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AKT1—lung cancer	1.64e-06	1.41e-05	CbGpPWpGaD
